Tracking and treating activated T cells

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 1, 2013, Pages 17-21

  Kim, N H ^a   Nadithe, V ^a   Elsayed, M ^a   Merkel, O M ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Activated T cells; Imaging; siRNA; Targeting; Theragnostics; Treatment

Indexed keywords

1 (2' DEOXY 2' FLUOROARABINOFURANOSYL)CYTOSINE F 18; BROMELAIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIALURIDINE I 124; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; POLYETHYLENEIMINE; RADIOPHARMACEUTICAL AGENT; SMALL INTERFERING RNA; TACROLIMUS; TECHNETIUM 99M; TRANSCRIPTION FACTOR GATA 3; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN PRESENTING CELL; ASTHMA; CHRONIC INFLAMMATION; COLITIS; COMPETITIVE INHIBITION; COST EFFECTIVENESS ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FLUORESCENCE IMAGING; GENE THERAPY; GRAFT VERSUS HOST REACTION; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOLECULAR IMAGING; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 84874074966     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50002-5     Document Type: Review

References (67)

1. Palmer E. - Negative selection - clearing out the bad apples from the T-cell repertoire. - Nat. Rev. Immunol., 3, 383-391, 2003. (Pubitemid 37323198)
2. Krammer P.H., Arnold R., Lavrik I.N. - Life and death in peripheral T cells. - Nat. Rev. Immunol., 7, 532-542, 2007.
3. Zhu J., Paul W.E. - Heterogeneity and plasticity of T helper cells. - Cell Research, 20, 4-12, 2010.
4. Finlay D., Cantrell D.A. - Metabolism, migration and memory in cytotoxic T cells. - Nat. Rev. Immunol., 11, 109-117, 2011.
5. Hennecke J., Wiley D.C. - T cell receptor-MHC interactions up close. - Cell, 104, 1-4, 2001.
6. Greenwald R.J., Freeman G.J., Sharpe A.H. - The B7 family revisited. - Annu. Rev. Immunol., 23, 515-48, 2005.
7. Sharpe A.H., Freeman G.J. - The B7-CD28 superfamily. - Nat. Rev. Immunol., 2, 116-26, 2002.
8. Billadeau D.D., Nolz J.C., Gomez T.S. - Regulation of T-cell activation by the cytoskeleton. - Nat. Rev. Immunol., 7, 131-143, 2007.
9. Krensky A.M., Weiss A., Crabtree G., Davis M.M., Parham P. - T-lymphocyte-antigen interactions in transplant rejection. - N. Engl. J. Med., 322, 510-7, 1990.
10. Gaston J.S., Bacon P.A. - T-cell induction of autoimmunity. - Autoimmunity, 1, 151-5, 1988.
11. Modigliani R., Mary J.Y., Simon J.F., Cortot A., Soule J.C., Gendre J.P., René E. - Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'étude therapeutique des affections inflammatoires digestives. - Gastroenterology, 98, 811-8, 1990. (Pubitemid 20095830)
12. Di Gialleonardo V., Signore A., Glaudemans A.W., Dierckx R.A., De Vries E.F. - N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. - J. Nucl. Med., 53, 679-86,
13. Swain S.L., Croft M., Dubey C., Haynes L., Rogers P., Zhang X., Bradley L.M. - From naive to memory T cells. - Immunol. Rev., 150, 143-67, 1996.
14. Cohen F.E., Kosen P.A., Kuntz I.D., Epstein L.B., Ciardelli T.L., Smith K. A. - Structure-activity studies of interleukln-2. - Science, 234, 349-52, 1986.
15. Becker M.D., Crespo S., Martin T.M., Planck S.R., Naramura M., Rosenbaum J.T. - Intraocular in vivo imaging of activated T-lymphocytes expressing green-fluorescent protein after stimulation with endotoxin. - Graefes Arch. Clin. Exp. Ophthalmol., 239, 609-12, 2001. (Pubitemid 32816182)
16. Signore A., Chianelli M., Ronga G., Pozzilli P., Beverley P.C. - In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes. - Prog. Clin. Biol. Res., 355, 229-38, 1990.
17. Abbs I.C., Pratt J.R., Dallman M.J., Sacks S.H. - Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123iodine-interleukin 2. - Transpl. Immunol., 1, 45-51, 1993.
18. D'Alessandria C., di Gialleonardo V., Chianelli M., Mather S.J., de Vries E.F., Scopinaro F., Dierck R.A., Signore A. - Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes. - Mol. Imaging Biol., 12, 539-46,
19. Desai B.B., Quinn P.M., Wolitzky A.G., Mongini P.K., Chizzonite R., Gately M.K. - IL-12 receptor. II. Distribution and regulation of receptor expression. - J. Immunol., 148, 3125-32, 1992.
20. Annovazzi A., D'Alessandria C., Bonanno E., Mather S.J., Cornelissen B., van de Wiele C., Dierckx R.A., Mattei M., Palmieri G., Scopinaro F., Signore A. - Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. - Eur. J. Nucl. Med. Mol. Imaging, 33, 474-82, 2006.
21. Ponomarev V., Doubrovin M., Lyddane C., Beresten T., Balatoni J., Bornman W., Finn R., Akhurst T., Larson S., Blasberg R., Sadelain M., Tjuvajev J.G. - Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. - Neoplasia, 3, 480-8, 2001. (Pubitemid 33151014)
22. Na I.K., Markley J.C., Tsai J.J., Yim N.L., Beattie B.J., Klose A.D., Holland A.M., Ghosh A., Rao U.K., Stephan M.T., Serganova I., Santos E.B., Brentjens R.J., Blasberg R.G., Sadelain M., van den Brink M.R. - Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo. - Blood, 116, e18-25, 2010.
23. Macian F. - NFAT proteins: key regulators of T-cell development and function. - Nat. Rev. Immunol., 5, 472-84, 2005.
24. Namavari M., Chang Y.F., Kusler B., Yaghoubi S., Mitchell B.S., Gambhir S.S. - Synthesis of 2′-deoxy-2′-[18F]fluoro-9-beta-D- arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET. - Mol. Imaging Biol., 13, 812-8,
25. 18F]-labeled 2′-deoxycytidine analog. - Nat. Med., 14, 783-8, 2008.
26. Siffrin V., Brandt A.U., Radbruch H., Herz J., Boldakowa N., Leuenberger T., Werr J., Hahner A., Schulze-Topphoff U., Nitsch R., Zipp F. - Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. - Brain, 132, 1247-58, 2009.
27. Herz J., Paterka M., Niesner R.A., Brandt A.U., Siffrin V., Leuenberger T., Birkenstock J., Mossakowski A., Glumm R., Zipp F., Radbruch H. - In vivo imaging of lymphocytes in the CNS reveals different behaviour of naive T cells in health and autoimmunity. - J. Neuroinflammation, 8, 131, 2011.
28. Sundstrom J.B., Mao H., Santoianni R., Villinger F., Little D.M., Huynh T.T., Mayne A.E., Hao E., Ansari A.A. - Magnetic resonance imaging of activated proliferating rhesus macaque T cells labeled with superparamagnetic monocrystalline iron oxide nanoparticles. - J. Acquir. Immune Defic. Syndr., 35, 9-21, 2004. (Pubitemid 38044777)
29. Jeffery P.K. - Pathology of asthma. - Br. Med. Bull., 48, 23-39, 1992.
30. Ray A., Cohn L. - Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. - J. Clin. Invest., 104, 985-93, 1999. (Pubitemid 29536304)
31. Gwinn W.M., Damsker J.M., Falahati R., Okwumabua I., Kelly-Welch A., Keegan A.D., Vanpouille C., Lee J.J., Dent L.A., Leitenberg D., Bukrinsky M.I., Constant S.L. - Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. - J. Immunol., 177, 4870-9, 2006. (Pubitemid 44469823)
32. Biedermann T., Schwarzler C., Lametschwandtner G., Thoma G., Carballido-Perrig N., Kund J., de Vries J.E., Rot A., Carballido J.M. - Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. - European Journal of Immunology, 32, 3171-80, 2002.
33. McKallip R.J., Do Y., Fisher M.T., Robertson J.L., Nagarkatti P.S., Nagarkatti M. - Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. - International Immunology, 14, 1015-26, 2002.
34. Batista A., Barata J.T., Raderschall E., Sallan S.E., Carlesso N., Nadler L.M., Cardoso A.A. - Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. - Experimental Hematology, 39, 457-472 e3, 2011.
35. Zheng Y., Collins S.L., Lutz M.A., Allen A.N., Kole T.P., Zarek P.E., Powell J.D. - A role for mammalian target of rapamycin in regulating T cell activation versus anergy. - J. Immunol., 178, 2163-70, 2007. (Pubitemid 46233414)
36. Moreno M.B., Titus J.A., Cole M.S., Tso J.Y., Le N., Paik C.H., Bakacs T., Zacharchuk C.M., Segal D.M., Wunderlich J.R. - Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo. - Cancer Immunology, Immunotherapy: CII, 40, 182-90, 1995.
37. Ramos-Casals M., Brito-Zeron P. - Emerging biological therapies in primary Sjogren's syndrome. - Rheumatology (Oxford, England), 46, 1389-96, 2007. (Pubitemid 47317084)
38. Smolen J.S. - What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials. - The Journal of Rheumatology, Supplement, 79, 15-20, 2007. (Pubitemid 47067972)
39. Toh M.L., Miossec P. - The role of T cells in rheumatoid arthritis: new subsets and new targets. - Current Opinion in Rheumatology, 19, 284-8, 2007. (Pubitemid 46597468)
40. VanderBorght A., De Keyser F., Geusens P., De Backer M., Malaise M., Baeten D., Van den Bosch F., Veys E.M., Raus J., Stinissen P. - Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral). - The Journal of Rheumatology, 29, 416-26, 2002. (Pubitemid 34202807)
41. Weyand C.M., Goronzy J.J. - T-cell-targeted therapies in rheumatoid arthritis. - Nature Clinical Practice. Rheumatology, 2, 201-10, 2006.
42. O'Reilly S., Hugle T., van Laar J.M. - T cells in systemic sclerosis: a reappraisal. - Rheumatology (Oxford, England), 2012.
43. Atreya R., Zimmer M., Bartsch B., Waldner M.J., Atreya I., Neumann H., Hildner K., Hoffman A., Kiesslich R., Rink A.D., Rau T.T., Rose-John S., Kessler H., Schmidt J., Neurath M.F. - Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages. - Gastroenterology, 141, 2026-38, 2011.
44. Yang Y.H., Rajaiah R., Ruoslahti E., Moudgil K.D. - Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis. - Proc. Natl. Acad. Sci. USA, 108, 12857-62, 2011.
45. Ye Q., Fraser C.C., Gao W., Wang L., Busfield S.J., Wang C., Qiu Y., Coyle A.J., Gutierrez-Ramos J.C., Hancock W.W. - Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. - The Journal of Experimental Medicine, 195, 795-800, 2002. (Pubitemid 34259724)
46. Weinberg A.D. - OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines. - Trends in Immunology, 23, 102-9, 2002. (Pubitemid 34310152)
47. Boumedine R.S., Roy D.C. - Elimination of alloreactive T cells using photodynamic therapy. - Cytotherapy, 7, 134-43, 2005.
48. Hunt D.W., Jiang H., Granville D.J., Chan A.H., Leong S., Levy J.G. - Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. - Immunopharmacology, 41, 31-44, 1999. (Pubitemid 29044108)
49. Beeton C., Wulff H., Barbaria J., Clot-Faybesse O., Pennington M., Bernard D., Cahalan M.D., Chandy K.G., Beraud E. - Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. - Proc. Natl. Acad. Sci. USA, 98, 13942-7, 2001. (Pubitemid 33116003)
50. Beeton C., Pennington M.W., Wulff H., Singh S., Nugent D., Crossley G., Khaytin I., Calabresi P.A., Chen C.Y., Gutman G.A., Chandy K.G. - Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. - Molecular Pharmacology, 67, 1369-81, 2005. (Pubitemid 40410438)
51. Vianna-Jorge R., Suarez-Kurtz G. - Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders? BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 18, 329-41, 2004. (Pubitemid 39381949)
52. Albert M.L., Austin L.M., Darnell R.B. - Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. - Ann. Neurol., 47, 9-17, 2000.
53. Secor E.R., Jr., Singh A., Guernsey L.A., McNamara J.T., Zhan L., Maulik N., Thrall R.S. - Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro. - Int. Immunopharmacol., 9, 340-6, 2009.
54. Secor E.R., Carson W.F., Singh A., Pensa M., Guernsey L.A., Schramm C.M., Thrall R.S. - Oral bromelain attenuates inflammation in an ovalbumin-induced murine model of asthma. - Evid Based Complement Alternat. Med., 5, 61-9, 2008. (Pubitemid 351301948)
55. Hale L.P., Haynes B.F. - Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. - J. Immunol., 149, 3809-16, 1992. (Pubitemid 23068859)
56. Barnes J. - Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety. - Br. J. Clin. Pharmacol., 55, 331-40, 2003. (Pubitemid 36537817)
57. Khan I.A. - Issues related to botanicals. - Life Sci., 78, 2033-8, 2006.
58. Shen Y., Luo Q., Xu H., Gong F., Zhou X., Sun Y., Wu X., Liu W., Zeng G., Tan N., Xu Q. - Mitochondria-dependent apoptosis of activated T lymphocytes induced by astin C, a plant cyclopeptide, for preventing murine experimental colitis. - Biochem. Pharmacol., 82, 260-8, 2011.
59. Sun Y., Qin Y., Gong F.Y., Wu X.F., Hua Z.C., Chen T., Xu Q. - Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice. - Biochem. Pharmacol., 77, 1717-24, 2009.
60. Dardalhon V., Herpers B., Noraz N., Pflumio F., Guetard D., Leveau C., Dubart-Kupperschmitt A., Charneau P., Taylor N. - Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. - Gene Ther., 8, 190-8, 2001. (Pubitemid 32186130)
61. Tervo H.M., Allespach I., Keppler O.T. - High-level transfection of primary rabbit T lymphocytes. - J. Immunol. Methods, 336, 85-9, 2008.
62. Gust T.C., Neubrandt L., Merz C., Asadullah K., Zugel U., von Bonin A. - RNA interference-mediated gene silencing in murine T cells: in vitro and in vivo validation of proinflammatory target genes. - Cell Commun. Signal, 6, 3, 2008.
63. Lee J., Yun K.S., Choi C.S., Shin S.H., Ban H.S., Rhim T., Lee S.K., Lee K.Y. - T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles. - Bioconjug Chem, e-pub ahead of print.
64. Neckers L.M., Cossman J. - Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. - Proc. Natl. Acad. Sci. USA, 80, 3494-8, 1983. (Pubitemid 13060190)
65. Debus H., Kilic A., Schiller M., Zheng M., Renz H., Kissel T., Merkel O.M. - Targeting human and murine T-cells using novel low molecular weight poly(ethylene imine)-transferrin-bioconjugates. - In preparation.
66. Sel S., Wegmann M., Dicke T., Sel S., Henke W., Yildirim A.Ö., Renz H., Gam H. - Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. - Journal of Allergy and Clinical Immunology, 121, 910-916.e5, 2008.
67. Barnes P.J. - Immunology of asthma and chronic obstructive pulmonary disease. - Nat. Rev. Immunol., 8, 183-192, 2008. (Pubitemid 351323287)